-
Solidion Technology Announced AI-Assisted Design and Manufacturing Technology of Bipolar Solid-State Batteries for Space Vehicles, Ground, Sea, Air and Infrastructure
The company’s revolutionary, patented bipolar electrode-to-pack technology increases the battery energy and power densities; reducing weight, volume, and cost DALLAS, June 16, 2026 /PRNewswire/ — Solidion Technology, Inc. (Nasdaq: STI), an advanced battery technology solutions provider, today unveiled their patented bipolar electrode-to-pack (BEEP) battery technology, engineered to power electric vertical take-off and landing (eVTOL) aircraft,…
-
LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China
The New Drug Application for LNZ100 in China was submitted September 2025 with approval anticipated in Q1 2027 June 07, 2026 19:30 ET | Source: LENZ Therapeutics, Inc. SAN DIEGO, June 07, 2026 (GLOBE NEWSWIRE) — LENZ Therapeutics, Inc. (Nasdaq: LENZ, “LENZ” or the “Company”), a pharmaceutical company focused on the commercialization of VIZZ® (aceclidine…
-
Solidion Technology’s 30+ Patents for Space-Based Artificial Intelligence Batteries Include the Highest-Performing Patented Lithium Anode Protection Technology
Game-Changing Anode Protection Platform Enabling All Ultra-High Energy Lithium Metal Batteries for Space and Commercial Applications DALLAS, June 5, 2026 /PRNewswire/ — Solidion Technology Inc. (“Solidion” or the “Company”) (NASDAQ: STI), an advanced battery technology solutions provider, today announced a patented breakthrough in lithium metal battery technology that removes the key stumbling blocks against full-scale…
-
Quantinuum Announces Closing of Upsized Initial Public Offering
BROOMFIELD, Colo., June 5, 2026 /PRNewswire/ — Quantinuum Inc. (Nasdaq: QNT) (“Quantinuum”) today announced the closing of its upsized initial public offering of 28,000,000 shares of its Class A common stock at an initial public offering price of $60.00 per share. All of the shares were offered by Quantinuum. The aggregate gross proceeds from the…
-
Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea®
REYKJAVIK, Iceland, June 4, 2026 – Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the resubmission to the U.S. Food and Drug Administration (FDA) of Biologics License Applications (BLAs) for AVT05, a proposed biosimilar to Simponi® and Simponi Aria® (golimumab), and AVT06,…
-
Solidion Technology Unveils Patented Extreme-Climate Battery Technology Targeting Low Earth Orbit-Based Artificial Intelligence Data Centers, Lunar Economy, and Space
Proprietary Gen-ECB Platform Engineered for Satellites, Starship Operations, Artemis Missions, and Orbital Infrastructure — Positioning Solidion at the Forefront of the Commercial Space Boom DALLAS, June 4, 2026 /PRNewswire/ — Solidion Technology Inc. (“Solidion” or the “Company”) (Nasdaq: STI), an advanced battery technology solutions provider, today announced a patented breakthrough in extreme-climate battery technology and…
-
Silvio Napoli Assumes Role as CEO of Lucid Following Completion of Leadership Transition
NEWARK, Calif., June 1, 2026 /PRNewswire/ — Lucid Group, Inc. (NASDAQ: LCID), maker of the world’s most advanced software-defined vehicles and technologies, today announced that Silvio Napoli has assumed the role of Chief Executive Officer (CEO), effective immediately. Napoli was previously announced as incoming CEO on April 14. “On behalf of the Board, we are pleased…
-
J-Star Holding Provides Additional Details on Baytown Economic Development Foundation LOI Supporting Proposed U.S. Solid-State Battery Manufacturing Facility
Formal LOI Details Site Selection Support, Infrastructure Requirements, 18-Month Site Availability Commitment, and Framework for Long-Term Facility Development June 01, 2026 11:50 ET | Source: J-Star Holding Co., Ltd TAICHUNG CITY, Taiwan, June 01, 2026 (GLOBE NEWSWIRE) — J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), today provided additional details regarding the commitment…
-
Zealand Pharma – Transactions related to share buy-back program (week 22, 2026)
Company announcement No. 20 / 2026 Zealand Pharma – Transactions related to share buy-back program (week 22, 2026) Copenhagen, Denmark, June 1, 2026 – Zealand Pharma A/S (“the Company” or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today reports transactions related to its share buy-back program (the…
-
Servier to Acquire Edgewise Therapeutics’ Muscular Dystrophy Business
Acquisition supports Servier’s strategic ambition in rare neurology for patients with high unmet medical needs. Transaction includes sevasemten, a late-stage investigational treatment for Becker and Duchenne muscular dystrophies. Transaction represents total value of up to $2.65 billion. SURESNES, France, June 1, 2026 /PRNewswire/ — Servier, an independent international pharmaceutical group governed by a foundation, today announced that…
-
TaskUs Honored at Times Business Awards for Driving the Future of AI-Powered Customer Experience
New Delhi, Delhi, India TaskUs (Nasdaq: TASK), a leading provider of outsourced digital services that power the companies shaping the future, has been honored at the prestigious Times Business Awards held in New Delhi. The company received the award for ‘Powering AI-Led CX Evolution and Innovation’, recognizing its contribution to advancing customer experience through technology-led…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
